摘要
目的 分析急诊内科治疗老年重症心力衰竭患者的临床效果.方法 选取2017年2月至2019年2月吉林市龙潭人民医院收治的老年重症心力衰竭患者88例,按就诊时间随机分为试验组与参照组,每组44例.参照组患者予以常规治疗,试验组患者则加以厄贝沙坦氢氯噻嗪和美托洛尔进行治疗.比较2组患者的临床疗效及治疗前后的左室射血分数(LVEF)和B型脑钠肽(BNP)水平.结果 试验组治疗的总有效率明显高于参照组,差异有统计学意义(93.18% vs. 75.00%,P<0.05).2组患者治疗前LVEF、BNP水平比较,差异无统计学意义(P>0.05).治疗后,2组患者的LVEF水平上升,BNP水平下降(P<0.05),且试验组优于参照组(P<0.05).结论 老年重症心力衰竭患者采用厄贝沙坦氢氯噻嗪和美托洛尔进行急诊内科治疗,能够提高临床治疗效果,更有效改善患者临床指标和症状.
Objective To analyze the clinical effect of emergency internal medicine in treating elderly patients with severe heart failure.Methods A total of 88 elderly patients with severe heart failure admitted to the emergency Department of Jilin Longtan People's Hospital from February 2017 to February 2019 were selected and were randomly divided into the experimental group and the reference group according to the admission time,with 44 cases in each group.The reference group was treated routinely,while the g experimental roup was treated with irbesartan hydrochlorothiazide and metoprolol.The clinical effect and left ventricular ejection fraction(LVEF)and B-type brain natriuretic peptide(BNP)before and after treatment were compared between the two groups Results The total effective rate of the experimental group was higher than the reference group,the difference was statistically significant(93.18%vs.75.00%,P<0.05).There was no significant difference in LVEF and BNP levels between the two groups before treatment(P>0.05).After treatment,LVEF level increased and BNP level decreased in both groups(P<0.05),and the experimental group was superior to the reference group(P<0.05).Conclusion Erbesartan hydrochlorothiazide and metoprolol for emergency medical treatment of elderly patients with severe heart failure can improve the clinical treatment effect,more effectively improve the clinical indicators and symptoms of patients,with a good application value.
作者
徐晓琨
XU Xiaokun(Jilin Longtan People's Hospital,Jilin,Jilin 132011,China)
出处
《大医生》
2019年第21期37-39,共3页
Doctor
关键词
急诊内科
美托洛尔
临床效果
老年重症心力衰竭患者
emergency medicine
metoprolol
clinical effect
elderly patients with severe heart failure